Literature DB >> 15060518

Comparison between dopaminergic agents and physical exercise as treatment for periodic limb movements in patients with spinal cord injury.

M T De Mello1, A M Esteves, S Tufik.   

Abstract

STUDY
DESIGN: Randomized controlled trial of physical exercise and dopaminergic agonist in persons with spinal cord injury and periodic leg movement (PLM).
OBJECTIVE: The objective of the present study was to compare the effectiveness of physical exercise and of a dopaminergic agonist in reducing the frequency of PLM.
SETTING: Centro de Estudos em Psicobiologia e Exercício. Universidade Federal de São Paulo, Brazil.
METHODS: A total of 13 volunteers (mean age: 31.6+/-8.3 years) received L-DOPA (200 mg) and benserazide (50 mg) 1 h before sleeping time for 30 days and were then submitted to a physical exercise program on a manual bicycle ergometer for 45 days (3 times a week).
RESULTS: Both L-DOPA administration (35.11-19.87 PLM/h, P<0.03) and physical exercise (35.11-18.53 PLM/h, P<0.012) significantly reduced PLM; however, no significant difference was observed between the two types of treatment.
CONCLUSIONS: The two types of treatment were found to be effective in the reduction of PLM; however, physical exercise is indicated as the first treatment approach, while dopaminergic agonists or other drugs should only be recommended for patients who do not respond to this type of treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060518     DOI: 10.1038/sj.sc.3101575

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  17 in total

Review 1.  Recovery of control of posture and locomotion after a spinal cord injury: solutions staring us in the face.

Authors:  Andy J Fong; Roland R Roy; Ronaldo M Ichiyama; Igor Lavrov; Grégoire Courtine; Yury Gerasimenko; Y C Tai; Joel Burdick; V Reggie Edgerton
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

2.  Epidemiology of exercise and sleep.

Authors:  Shawn D Youngstedt; Christopher E Kline
Journal:  Sleep Biol Rhythms       Date:  2006-08       Impact factor: 1.186

3.  Serotonin receptor and dendritic plasticity in the spinal cord mediated by chronic serotonergic pharmacotherapy combined with exercise following complete SCI in the adult rat.

Authors:  Patrick D Ganzer; Carl R Beringer; Jed S Shumsky; Chiemela Nwaobasi; Karen A Moxon
Journal:  Exp Neurol       Date:  2018-03-09       Impact factor: 5.330

4.  Periodic limb movements in tetraplegia.

Authors:  Annemieke Emma Josina Peters; Lysanne van Silfhout; Marnie Graco; Rachel Schembri; Dick Thijssen; David J Berlowitz
Journal:  J Spinal Cord Med       Date:  2017-05-02       Impact factor: 1.985

5.  Dopaminergic treatment of restless legs syndrome in spinal cord injury patients with neuropathic pain.

Authors:  Hatice Kumru; Sergiu Albu; Joan Vidal; Manuela Barrio; Joan Santamaria
Journal:  Spinal Cord Ser Cases       Date:  2016-08-18

6.  Behavioral Sleep Medicine Interventions for Restless Legs Syndrome and Periodic Limb Movement Disorder.

Authors:  Wilfred R Pigeon; Michael Yurcheshen
Journal:  Sleep Med Clin       Date:  2009-12-01

Review 7.  Sleep-associated movement disorders and heart failure.

Authors:  Troy Schaffernocker; Julia Ho; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 8.  Cortical reorganization after spinal cord injury: always for good?

Authors:  K A Moxon; A Oliviero; J Aguilar; G Foffani
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

9.  Interactive Effects Between Exercise and Serotonergic Pharmacotherapy on Cortical Reorganization After Spinal Cord Injury.

Authors:  Guglielmo Foffani; Jed Shumsky; Eric B Knudsen; Patrick D Ganzer; Karen A Moxon
Journal:  Neurorehabil Neural Repair       Date:  2015-09-03       Impact factor: 3.919

10.  Passive exercise of the hind limbs after complete thoracic transection of the spinal cord promotes cortical reorganization.

Authors:  Alessandro Graziano; Guglielmo Foffani; Eric B Knudsen; Jed Shumsky; Karen A Moxon
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.